Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-25 @ 2:43 AM
NCT ID:
NCT01396733
Eligibility Criteria:
Inclusion Criteria:
1. aged 20 to 75 years
2. under birth control, if fertile women
3. Groups
* who received radioactive iodine treatment for recurrent and metastatic thyroid cancer, and did not showed any uptake at post-therapeutic whole body scan
* who planned to receive empirical radioactive treatment due to high expected recurrence
Exclusion Criteria:
* allergic to alpha-lipoic acid
* severe heart failure, lung disease, or end-stage renal disease
* liver function abnormalities (x2.5 above normal limits)
* neuropsychologically unstable patients
* previous history of drug medication such as oral steroid, digoxin, theophylline, carbamazepine, valproic acid, phenobarbital, methotrexate, cyclosporin, tacrolimus within 3 months before this recruitment.
* who is already taking alpha-lipoic acid for other purpose.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT01396733
Study Brief:
Protocol Section:
NCT01396733